Covered recipient · General Payments record
LUIS J ACOSTA
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2018–2024
$2,571.45
- Reported across 99 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $525.00 | 1 |
| Food and Beverage | $419.98 | 22 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Daiichi Sankyo Inc. | $525.00 | 1 |
| ABBVIE INC. | $179.67 | 11 |
| Gilead Sciences, Inc. | $49.98 | 2 |
| PFIZER INC. | $38.01 | 2 |
| Merck Sharp & Dohme Corporation | $31.36 | 1 |
| AIMMUNE THERAPEUTICS, INC. | $23.79 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $23.49 | 1 |
| Madrigal Pharmaceuticals | $23.03 | 1 |
| La Jolla Pharmaceutical Company | $21.49 | 1 |
| ConvaTec Inc. | $14.94 | 1 |
| GENZYME CORPORATION | $14.22 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (23)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $15.94 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103172408 | CMS |
| ABBVIE INC. | $21.78 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103172410 | CMS |
| ABBVIE INC. | $18.80 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103172412 | CMS |
| ABBVIE INC. | $12.51 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103172414 | CMS |
| ABBVIE INC. | $21.23 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103172416 | CMS |
| ABBVIE INC. | $14.60 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103172418 | CMS |
| ABBVIE INC. | $15.74 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103172420 | CMS |
| ABBVIE INC. | $19.64 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103172422 | CMS |
| ABBVIE INC. | $11.10 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103172424 | CMS |
| ABBVIE INC. | $17.57 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103172426 | CMS |
| ABBVIE INC. | $10.76 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103172428 | CMS |
| AIMMUNE THERAPEUTICS, INC. | $23.79 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146986140 | CMS |
| ConvaTec Inc. | $14.94 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151369429 | CMS |
| Daiichi Sankyo Inc. | $525.00 | 11/02/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1084193850 | CMS |
| GENZYME CORPORATION | $14.22 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139938075 | CMS |
| Gilead Sciences, Inc. | $24.98 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133787717 | CMS |
| Gilead Sciences, Inc. | $25.00 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133787719 | CMS |
| La Jolla Pharmaceutical Company | $21.49 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154246758 | CMS |
| Madrigal Pharmaceuticals | $23.03 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144159427 | CMS |
| Merck Sharp & Dohme LLC | $31.36 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141752140 | CMS |
| PFIZER INC. | $14.94 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131287013 | CMS |
| PFIZER INC. | $23.07 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132118664 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $23.49 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153462516 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.